Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $92
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood maintains an Overweight rating on Boston Scientific (NYSE:BSX) and raises the price target from $79 to $92.
July 15, 2024 | 4:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley analyst Patrick Wood maintains an Overweight rating on Boston Scientific and raises the price target from $79 to $92.
The raised price target and maintained Overweight rating from a reputable analyst at Morgan Stanley is likely to positively impact investor sentiment and drive short-term price appreciation for Boston Scientific.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100